Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISDIPLAM vs RITONAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISDIPLAM vs RITONAVIR: Safety Overview

Metric RISDIPLAM RITONAVIR
Total FAERS Reports 3,619 11,980
Deaths Reported 336 1,190
Death Rate 9.3% 9.9%
Hospitalizations 719 2,925
Average Patient Age 21.8 yrs 43.8 yrs
% Female Patients 55.2% 43.8%
FDA Approval Date Aug 7, 2020 Dec 3, 2020
Manufacturer Genentech, Inc. AbbVie Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued